Telerehabilitation in Patients With Fibromyalgia
- Disease/Condition
- Fibromyalgia
- Drug/Device/Intervention
- Exercise Program
- Study type
- Interventional
- Intervention type
- other
- Primary sponsor
- Marmara University
- Location
- Istanbul, Turkey
- Phase
- N/A
- Start date
- May 27, 2023
- End date
- Jan 27, 2024
- Enrollment
- 66 participants
Visual Analog Scale
Sixty-six FMS patients received the same exercise program for 8 weeks and divided,
 synchronous (n: 33), asynchronous (n: 33). Pain (Visual analog Scale, VAS), functional
 limitations and disabilities (Revised Fibromyalgia Impact Questionnaire, FEA), health-related
 quality of life (HRQol; Short Form-12, SF 12), catastrophizing (pain catastrophizing scale,
 PCS), anxiety and depression (Hospital Anxiety and Depression Scale, HAD), functional
 capacity (6-minute walking test, 6MWT), muscle strength (Arm curl test) joint position sense
 (Laser Cursor Assisted Angle Repetition Test, LI-RATT) were assessed at baseline,
 mid-treatment (week 4), end of treatment (week 8), and eight weeks after treatment (week 16).
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06299527
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06299527 through Pure Global AI's free database. This phase not specified trial is sponsored by Marmara University and is currently Completed. The study focuses on Fibromyalgia. Target enrollment is 66 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.